File size: 1,682 Bytes
95a9764 | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 | {
"term": "Adderall",
"role": "concept",
"parent_concepts": [
"Mixture"
],
"layer": 4,
"domain": "PhysicalWorld",
"definition": "Adderall and Mydayis are\ntrade names for a combination drug containing four salts of\n&%Amphetamine. The mixture is composed of equal parts racemic\namphetamine and dextroamphetamine, which produces a (3:1) ratio\nbetween dextroamphetamine and levoamphetamine, the two enantiomers of\namphetamine. Both enantiomers are &%timulants, but differ enough to\ngive Adderall an effects profile distinct from those of racemic\namphetamine or dextroamphetamine, which are marketed as Evekeo\nand Dexedrine/Zenzedi, respectively. Adderall is used in the\ntreatment of attention deficit hyperactivity disorder (&%ADHD) and\nnarcolepsy. It is also used as an athletic performance enhancer,\ncognitive enhancer, appetite suppressant, and recreationally as an\naphrodisiac and euphoriant. It is a central nervous system (CNS)\nstimulant of the phenethylamine class.[from Wikipedia]",
"definition_source": "SUMO",
"aliases": [
"adderall"
],
"wordnet": {
"synsets": [
"adderall.n.01"
],
"canonical_synset": "adderall.n.01",
"lemmas": [
"adderall"
],
"pos": "noun"
},
"relationships": {
"related": [],
"antonyms": [],
"has_part": [],
"part_of": []
},
"safety_tags": {
"risk_level": "low",
"impacts": [],
"treaty_relevant": false,
"harness_relevant": false
},
"training_hints": {
"positive_examples": [],
"negative_examples": [],
"disambiguation": "",
"seed_terms": [
"adderall"
]
},
"is_category_lens": true,
"child_count": 0
} |